MBMikolaj Bartosik

Mikolaj Bartosik

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikolaj Bartosik has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Response to the Letter to the Editor on “Interpreting romosozumab-associated BMD changes in osteogenesis imperfecta: design, densitometry, and multiplicity”

    by Felix N. von Brackel, Mikolaj Bartosik, Oskar Windels, Michael Amling, Ralf Oheim

    We respond to methodological questions raised in a “Letter to the Editor” regarding our retrospective case series on romosozumab treatment in osteogenesis imperfecta (OI). We clarify that the retrospective study design, the rarity of the disease, the small number of cases, and the exploratory nature of the analyses limit the methodological approaches as already acknowledged in our original manuscript. Thus, the primary concern is an inherent limitation of an exploratory study in a rare disease. Nevertheless, these data are helpful, as they generate new hypotheses given the currently very limited clinical data available.

  • Open Access

    Implementing a hip arthroplasty program in Greenland, the autonomous territory of Denmark: challenges and outcomes

    by Mikolaj Bartosik, Najannguaq Jørgensen, Reinhard Stoewe

    Background and purpose: Greenland is undergoing rapid societal change, while its healthcare system faces substantial geographic and structural challenges. In January 2024, a routine program was established for elective total hip arthroplasty (THA) and hip replacements following femoral neck fractures. Patients and methods: All patients receiving hip replacement from January 2024 to January 2026 were analyzed retrospectively. Demographic parameters, complications, revision rates, one month mortality were evaluated and compared primarily with register data from Denmark, Greenland’s parent country. Results: A total of 123 patients (129 procedures) were assessed. Elective THA patients were younger (60 vs 68 years), had a higher body mass index (BMI) (29.9 vs 27.6), similar American Society of Anesthesiologists (ASA) scores, longer operative times (110 vs 92 min), lower blood loss (ΔHb -2.1 vs -2.3 g/dL), longer length of stay (discharge post-OP day 4.2 vs 1) and substantially higher complication rates than Danish controls. Hip fracture patients were younger (74 vs 79 years), had a lower BMI (23.9 vs 26), had a similar ASA distribution, lower blood loss (ΔHb -1.3 vs -3.4 g/dL), a similar post-OP discharge day (7.9 vs 7), and also numerically higher complication rates than Danish controls. Conclusion: Hip arthroplasty outcomes in Greenland were less favorable than in Denmark, likely due to various systemic and patient-related factors. Continuous efforts are required to optimize patient safety and clinical outcomes in this setting.

  • Open Access

    Distinct Cortical Microstructure in Postmenopausal Women with Distal Radius and Proximal Humerus Fractures

    by Mikolaj Bartosik, Alexander Simon, Oskar Windels, Felix N. von Brackel, Florian Barvencik, Michael Amling, Ralf Oheim

    Distal radius fractures and proximal humerus fractures are common fractures in postmenopausal women with osteoporosis. The question of whether bone microstructural deficits are reflected in specific changes in bone microstructure at peripheral skeletal sites has not yet been investigated. In this retrospective study, treatment-naïve postmenopausal women with distal radius fractures (DRF) or proximal humerus fractures (PHF) were included. Of more than 500 patients screened, 30 patients with DRF and 30 patients with PHF were included in the final analysis following propensity score matching. All participants underwent biochemical testing, dual-energy X-ray absorptiometry assessment, and bone microstructural evaluation by high-resolution peripheral quantitative computed tomography. After propensity score matching, both groups showed no significant differences in terms of age, weight, height, BMI, and lowest T-score (all p > 0.05). Mean age was 64.4 ± 10.7 years in the DRF group and 66.7 ± 9.0 years in the PHF group ( p = 0.365). In both groups, the lowest mean T-score was − 2.9 ( p = 0.539). Overall, both groups showed a reduction in total BMD and microarchitectural parameters compared to reference values at the distal radius and tibia. The PHF group exhibited significantly reduced bone geometry at the distal radius compared with the DRF group, including lower total area (p = 0.004), trabecular area ( p = 0.021), and cortical area ( p = 0.006), as well as reduced cortical thickness at both the distal radius ( p = 0.031) and tibia ( p = 0.024). PHF are characterized by reduced cortical thickness and unfavorable bone geometry, which is independent of areal bone mineral density.

  • Open Access

    Atypical Femoral Fractures in Adult Patients with Classical Osteogenesis Imperfecta

    by Mikolaj Bartosik, Oskar Windels, Florian Barvencik, Michael Amling, Ralf Oheim

    Atypical femoral fractures (AFF) are rare fractures with characteristic radiographic features, most commonly associated with long-term bisphosphonate use. Their occurrence in patients with osteogenesis imperfecta (OI), a hereditary bone disease leading to bone fragility, is not well understood. In this study, 138 adults with genetically confirmed classical OI were screened for AFF. Five patients with AFF were identified and compared to an age- and treatment-matched adult OI cohort without AFF ( n = 23). Demographical parameters, biochemical markers, bone mineral density (DXA), bone microarchitecture (HR-pQCT), and radiographs were analyzed. In addition, antiresorptive therapy and the duration of treatment were determined and compared. In the screened OI cohort, AFF prevalence was 3.6%. No significant differences were observed between groups regarding age, weight, height, BMI, fracture history, bone mineral density, or antiresorptive therapy exposure and duration. HR-pQCT showed no significant microarchitectural differences, although a trend toward higher cortical thickness was noted in AFF patients. AFF are a rare complication in adults with classical OI and appear to be multifactorial in origin. Our findings suggest that AFF are not exclusively related to antiresorptive therapy but may be influenced by disease-specific factors, particularly the underlying collagen defect, femoral deformities and altered biomechanics. Individualized management strategies are essential, and further studies are needed to clarify underlying mechanisms and best treatment options.

  • Open Access

    Individualized antiresorptive therapy in fibrous dysplasia and McCune-Albright syndrome: A retrospective cohort study

    by Tonio Lipkow, Mikolaj Bartosik, Johann Sprick-Schütte, Florian Barvencik, Michael Amling, Ralf Oheim

  • Open Access

    Multiscale imaging reveals compartment-specific mechanobiology of the osteochondral unit in knee osteoarthritis

    by Alexander Simon, Victoria Simon, Assil-Ramin Alimy, Kirsten Schleid, Ana Ocokoljic, Mikolaj Bartosik, Simon von Kroge, Haider Mussawy, Michael Amling, Frank Timo Beil, et al.


  • Open Access

    Bone turnover in postmenopausal women during denosumab treatment: Biomarker analysis in naive and discontinuing patients

    by Mikolaj Bartosik, Esther Wolf, Alexander Simon, Felix N. von Brackel, Oskar Windels, Ulrich C. Klostermeier, Florian Barvencik, Michael Amling, Ralf Oheim


  • Frakturen und Frakturheilungsstörungen bei adulter Hypophosphatasie: Eine Übersicht

    by Oskar Windels, Florian Dudde, Mikolaj Bartosik, Timur Yorgan, Florian Barvencik

    Zusammenfassung: Die genetisch bedingte Stoffwechselerkrankung Hypophosphatasie (HPP) ist durch eine verminderte Aktivität der gewebeunspezifischen alkalischen Phosphatase (TNSALP) charakterisiert, bei der die Akkumulation von Mineralisationsinhibitoren zu Osteomalazie, zu erhöhter Fragilität von Knochen und zu gestörter Frakturheilung führen kann. Bei Erwachsenen, können niedrigtraumatische metatarsale Insuffizienzfrakturen, atypische Femurfrakturen und verzögerte Frakturheilung im Rahmen der HPP auftreten. Ziel : Darstellung des aktuellen Wissenstandes bei Diagnostik und Therapie von Frakturen und Frakturheilungsstörung bei HPP-Patient:innen. Es erfolgte eine Analyse der Literatur zu dem Thema im Sinne eines narrativen Reviews auf Basis einer PubMed-Suche und der Referenzlisten einschlägiger Übersichtsarbeiten. Eingeschlossen in die Suche wurden klinische Studien, Fallserien, Fallberichte, Leitlinien und Konsensuspapiere. Rezidivierende metatarsale Frakturen und atypische Femurfrakturen gelten als Hauptkriterien, verzögerte Frakturheilung als Nebenkriterium für die Diagnose von HPP. Die Evidenzlage ist begrenzt. Die Recherche identifizierte zehn Fallberichte und Fallserien, zu Enzymersatztherapie mit Asfotase Alfa oder Therapie mit Teriparatid. Fallserien zeigen Hinweise, dass Asfotase Alfa die Konsolidierung auch langjähriger nicht heilender Frakturen verbessern kann. Teriparatid wurde in fünf Arbeiten als individualisierte Off-Label-Option mit heterogenen Ergebnissen beschrieben. Frühe Erkennung HPP-typischer Frakturen und strukturierte Diagnostik sind entscheidend, um eine Therapie einzuleiten. Trotz umfangreicher Studien zur Enzymersatztherapie existieren zur Frakturheilung nur Fallberichte und Fallserien, Gleiches gilt für Teriparatid.

  • Die chirurgische Stabilisierung von Fragilitätsfrakturen des Beckenrings zeigt unabhängig vom Operationsverfahren ein gutes altersentsprechendes Ergebnis

    by Anne Sofie Vogelsang, Mikolaj Bartosik, Eckart Mayr, Ulf Culemann

    The treatment of fragility fractures of the pelvis (FFP) is becoming increasingly more important due to the demographic changes. Older age and the associated multimorbidity pose a challenge for the optimal treatment of pelvic fractures. A total of 36 patients were included. They were categorized according to the FFP classification with the following distribution: 44.4% FFP II, 16.7% FFP III and 38.9% FFP IV. Transiliosacral screws used unilaterally/bilaterally (cannulated 7.3 mm titanium screws with 32 mm thread, MedTech J&J, Umkirch, Germany) were compared to a continuous transiliosacral sacral rod (cannulated 7.5 mm rod, Marquardt, Spachingen, Germany) for stabilization of the posterior pelvic ring (screw vs. rod) and in combination with or without a ventral supra-acetabular external fixator (steel Schanz screws with cross-connectors classified as ⌀Fix vs. Fix). The parameters measured were the duration of surgery, complication and revision rates and functional outcomes. The quality of life on the visual analogue scale (EQ-VAS), EQ-5D-5L index and Elderly Mobility Scale (EMS) were compared 1 day, 6 weeks and 6 months postoperatively. The mean age of the overall cohort was 81.5 ± 7.7 years and the overall mortality rate was 5.6%. The higher complication (29.4% vs. 17.6%, p = 0.419) and revision rates (5.9% vs. 0.0%, p = 0.310) of the screw group were not statistically significant. The EQ-VAS, EQ-5D-5L and EMS showed no significant differences between screw vs. rod. The fix group had a longer operation time (47.2 ± 9.2 min vs. 35.2 ± 20.2 min, p = 0.005) but a lower complication rate (11.1% vs. 28.0%, p = 0.306); however, their mobility was significantly reduced postoperatively and after 6 weeks (EMS day 1: 6 ± 4 vs. 11 ± 4, p = 0.003; week 6: 12 ± 2 vs. 16 ± 3, p = 0.010). Osteoporosis treatment had not been performed prior to the injury in 64.7% of the injured patients, 29.4% received a basic treatment for osteoporosis and 5.9% received specific treatment for osteoporosis. Surgical treatment of FFP II-IV showed a good clinical outcome with age-appropriate values after 6 months. The clinical outcome was the same after 6 months regardless of the surgical procedure.

  • Periprothetische Frakturen – Azetabulum

    by Mikolaj Bartosik, Eckart Mayr, Ulf Culemann

    Periprothetische Azetabulumfrakturen (PPAF) sind seltene Komplikationen in der Hüftendoprothetik, die hohe Komplikationsraten aufweisen. Ihre Behandlung erfordert eine präzise Beurteilung der Pfannenstabilität, der Beckenringstabilität und der Knochenqualität. Trotz neuer Klassifikationssysteme und Therapiealgorithmen fehlt es an belastbarer Evidenz, was zu variablen Behandlungsergebnissen führt. Operative Versorgungen sind meist notwendig, bergen aber signifikante Risiken aufgrund des Ausmaßes des Eingriffs und der Komorbidität der zumeist älteren Patienten. Article published online: 10 November 2025 © 2025. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany